May 2017 Issue Table Of Contents

From The Editor

• Do You See A Trend In Life Science Leader?

Feature Articles

• The Rocky Journey To Refocusing BioMarin
• Takeda Aims To Invent It Here & There
• Journey To The Corporate Boardroom
• Industry Explorers: Leading Business With Science — Part 2

Capitol Perspectives

• Provider Consolidation Raising Costs And Undermining Competition

Companies To Watch

• Noveome Biotherapeutics

Inside The Industry

• Funding For Biopharmas Targeting Urgent Bacterial Threats
• Where Others Have Failed, Genocea Sees Promise In T-Cell Vaccines
• Pharma Embraces The Cloud ... Cautiously
• Compassionate Use: The Family & Patient’s Perspective
• Educating Consumers About The Risks Of Counterfeit Medicines
• Biopharma IPR Trends
• Is The Cuban Biopharma Industry A Forerunner Of Pharma 3.0?

Leadership Lessons

• Lessons In Leadership: “SKILL”

Ask The Board

• What Do You See As The Best Opportunity For Industries (Within Healthcare) To Collaborate And Solve Big Issues?
• What Can Be Done To Improve Gender Balance In The Boardroom?
• What U.S. Government Initiative Do You Think Has Proven Most Beneficial To Sparking Innovation In The Drug Industry?